This was the stock's second consecutive day of losses.

Besides Wall Street's top -and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...

Research teams have developed a new approach to identifying the chemical composition of preservation fluids in historic jars ...

The healthcare industry is poised for growth driven by the rapid adoption of new and advanced medical technologies to enhance diagnosis. Hence, investors might consider investing in healthcare stocks, ...

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Repligen (RGEN – Research Report) today and set a price target of $207.00. The ...

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $53.00.

The AJ Bell team explores companies Smith & Nephews and Coda as they release full-year results in weekly outlook ...

See what some of this week's dividend activity looked like as well as see what is ahead for next week. Learn more here.

U.S. Pharmacogenomics Market Growth 2025 Pharmacogenomics, also known as pharmacogenetics, is a branch of genomic medicine that uses a pati ...

Italy Organoids and Spheroids Market Research Report The Italy organoids and spheroids market is projected to reach $36.6 million by 2032, ...

Warren Buffet's Berkshire Hathaway (BRK-B) will kick off earnings releases for the coming week when it reports on Saturday, ...